BioCryst Pharmaceuticals
BCRX
#4950
Rank
S$2.44 B
Marketcap
S$9.49
Share price
-1.14%
Change (1 day)
3.94%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2026 (TTM): -S$0.46 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are S$0.96 Billion. In 2025 the company made an earning of S$0.34 Billion, an increase over its 2024 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$0.46 Billion-232.09%
2025 S$0.34 B-407.51%
2024 -S$0.12 Billion-61.56%
2023 -S$0.3 Billion-7.43%
2022 -S$0.32 Billion34.42%
2021 -S$0.24 Billion-0.55%
2020 -S$0.24 Billion67.88%
2019 -S$0.15 Billion7.55%
2018 -S$0.14 Billion53.92%
2017 -S$84.78 Million19.29%
2016 -S$71.07 Million28.19%
2015 -S$55.44 Million-4.8%
2014 -S$58.24 Million50.09%
2013 -S$38.81 Million-23.29%
2012 -S$50.59 Million-26.19%
2011 -S$68.53 Million54.78%
2010 -S$44.28 Million150.1%
2009 -S$17.71 Million-49.43%
2008 -S$35.01 Million14.07%
2007 -S$30.69 Million-49.31%
2006 -S$60.55 Million72.87%
2005 -S$35.03 Million22.08%
2004 -S$28.69 Million75.3%
2003 -S$16.37 Million-25.36%
2002 -S$21.93 Million225.05%
2001 -S$6.75 Million-56.6%
2000 -S$15.55 Million50.63%
1999 -S$10.32 Million38.05%
1998 -S$7.48 Million-52.46%
1997 -S$15.73 Million58.44%
1996 -S$9.93 Million-14.44%
1995 -S$11.6 Million28.57%
1994 -S$9.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-S$3.27 Billion 614.06%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$9.22 B-2,116.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.17 Billion-63.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$39.53 M-108.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-S$0.29 Billion-37.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.42 Billion-8.15%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.6 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$28.69 Million-93.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-S$0.26 Billion-45.14%๐Ÿ‡บ๐Ÿ‡ธ USA